TAG:
managed care contract
First-Ever National Gathering Of Lab Sales Managers
By Robert Michel | From the Volume VI No. 4 – March 15, 1999 Issue
CEO SUMMARY: Here’s a news-making event for the clinical laboratory industry: a first-ever national meeting of the country’s best sales and marketing managers. Scheduled as a new addition to the EXECUTIVE WAR COLLEGE on May 11-13, it’s an unprecedented opportunity for the nation’s…
Pathology Consolidation Offers Many Local Benefits
By Robert Michel | From the Volume VI No. 3 – February 22, 1999 Issue
CEO SUMMARY: Consolidation of pathology practices can be a complex and drawn-out process. But it doesn’t have to be that way. During the 1990s, Bayless Pathmark of Cleveland grew from a two-man practice into a regional pathology resource numbering 22 pathologists and serving 10 hospital…
Top-Performing Labs at Executive War College
By Robert Michel | From the Volume VI No. 2 – February 1, 1999 Issue
CEO SUMMARY: Once again, Executive War College time approaches. Scheduled for May 11-12, 1999 at the New Orleans Sheraton, this year’s roster of innovative laboratories promises to provide valuable insight about winning strategies. An expanded program offers a lab industry first: a know…
PPM Giant MedPartners Exits Doctor Management
By Robert Michel | From the Volume V No. 16 – November 30, 1998 Issue
THIRD IN A SERIES WHAT DOES IT MEAN WHEN the largest companies in a multibillion dollar industry announce that they will “get out” of that business? That is the question which must be answered after MedPartners, Inc. joined PhyMatrix Corp. in p…
PathSOURCE Is Newest Pathology Consolidator
By Robert Michel | From the Volume V No. 15 – November 9, 1998 Issue
CEO SUMMARY: Based in New York, PathSOURCE becomes the newest pathology network and services company to hit the market. PathSOURCE’s organizers want to link “best in class” dermatopathologists and academic pathology subspecialists to compete for outreach pathology specimens. PathSOU…
SmithKline’s Strategies Now Delivering Benefits
By Robert Michel | From the Volume V No. 14 – October 19, 1998 Issue
CEO SUMMARY: Business strategy does make a difference. However, it sometimes takes years to appreciate the wisdom of choosing one strategy over another. In the case of SmithKline Beecham’s lab division, the decision to become sole-source provider to the nation’s largest HMOs may event…
Washington State’s PacLab Network Is A Regional Winner
By Robert Michel | From the Volume V No. 14 – October 19, 1998 Issue
CEO SUMMARY: As a regional laboratory network, PacLab is unusual in one respect: participating hospital laboratories did not meet endlessly to talk about what they should do. Instead, action was the operative word for these network organizers. Since becoming operational in 1996, their bia…
Pathology PPMs Unlike Most Other PPM Firms
By Robert Michel | From the Volume V No. 14 – October 19, 1998 Issue
PHYSICIAN PRACTICE MANAGEMENT (PPM) companies have arrived at pathology’s doorstep. For better or worse, a new era is pushing its way into the pathology profession. In the first installment of this exclusive DARK REPORT series, we exposed the rotten secret behind the …
Curse Of Consolidation Plagues Health Providers
By Robert Michel | From the Volume V No. 13 – September 28, 1998 Issue
WITHOUT QUESTION, today’s healthcare world is dominated by a single obvious trend: consolidation. The consequences of consolidation affect every segment of healthcare in the United States. The commercial laboratory industry had the dubious distinction of being the first major segment of healthcare…
Blunt Talk From HMO Blue’s Ancillary Contracts Manager
By Robert Michel | From the Volume V No. 11 – August 17, 1998 Issue
CEO SUMMARY: By now, most clinical laboratory executives and pathologists have discovered a new fact of life: provider status with managed care organizations is a critical success factor. Without provider status, the laboratory is denied access to patients and the reimbursement associated…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized